Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:46:46 EDT Sat 20 Apr 2024
Enter Symbol
or Name
USA
CA



Q:VAPO - VAPOTHERM INC - http://www.vaporin.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VAPO - Qnot subscribed1.26-0.16-11.39.512281.426  1.426  1.264.10  0.3415:59:40Mar 2015 min RT 2¢

Recent Trades - Last 10 of 28
Time ETExPriceChangeVolume
15:59:40Q1.26-0.16100
15:15:11Q1.29-0.13100
15:15:02Q1.34-0.0819
14:56:45Q1.29-0.131,481
14:51:39Q1.26-0.16222
14:51:34Q1.26-0.16578
14:51:33Q1.305-0.115578
14:51:05Q1.314-0.106100
14:32:35Q1.30-0.12100
13:51:20Q1.440.0299

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-20 08:30U:VAPONews ReleaseOnymos and Vapotherm Announce Partnership to Create an End-to-End Internet of Medical Things Solution (IoMT)
2024-03-15 07:36U:VAPONews ReleaseVapotherm to Unveil Access365 Home Ventilation Solution at MEDTRADE
2024-03-06 06:45U:VAPONews ReleaseDr. David Yamane was awarded the Star Research Award at the 2024 Critical Care Congress for the presentation of the HYPERACT Study - a randomized controlled trial demonstrating Vapotherm's High Velocity Therapy effectively treats moderate-severe acute exa
2024-02-29 06:45U:VAPONews ReleaseVapotherm's HVT 2.0 System Overcomes Regulatory Hurdles for Entry into South America's Largest Health Care Market
2024-02-22 16:10U:VAPONews ReleaseVapotherm Reports Fourth Quarter and Fiscal Year 2023 Financial Results
2023-12-15 07:00U:VAPONews ReleaseOTC Markets Group Welcomes Vapotherm, Inc. to OTCQX
2023-12-14 18:27U:VAPONews ReleaseVapotherm Announces Suspension of NYSE Listing Common Stock Expected to Begin Trading Promptly on OTCQX
2023-12-11 06:45U:VAPONews ReleaseVapotherm Announces Notification to New York Stock Exchange of Intention to Voluntarily Delist Common Stock Application Pending to Transfer Shares to OTCQX
2023-11-28 16:54U:VAPONews ReleaseVapotherm Educates over 8,000 Clinicians in Respiratory Care Month
2023-11-08 16:10U:VAPONews ReleaseVapotherm Reports Third Quarter 2023 Financial Results
2023-11-01 06:45U:VAPONews ReleaseVapotherm To Report Third Quarter 2023 Financial Results
2023-10-04 06:45U:VAPONews ReleaseComputational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic high flow cannulas
2023-09-25 06:45U:VAPONews ReleasePilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children
2023-08-08 16:10U:VAPONews ReleaseVapotherm Reports Second Quarter 2023 Financial Results
2023-07-25 16:30U:VAPONews ReleaseVapotherm To Report Second Quarter 2023 Financial Results
2023-05-03 16:10U:VAPONews ReleaseVapotherm Reports First Quarter 2023 Financial Results
2023-04-27 16:30U:VAPONews ReleaseVapotherm To Report First Quarter 2023 Financial Results